Efficacy and safety of dostarlimab plus chemotherapy in patients with endometrial cancer by age category in part 1 of the ruby trial


Gold M., Bolling M. F., Sharma S., Kommoss S., Gilbert L., Ring K., ...More

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, no.SUPPL_3, 2024 (SCI-Expanded) identifier